Terry Hudson

Terry Hudson is an accomplished executive in the biotechnology industry, currently serving as the Executive Director of Manufacturing Sciences & Technology and Manufacturing Operations at Denali Therapeutics, where responsibilities include overseeing a new clinical manufacturing site in Salt Lake City, Utah, since April 2023. Prior experience includes an extensive tenure at Genentech from September 2006 to April 2023, culminating in the role of Executive Director of SSFP Manufacturing Sciences and Technology, with previous positions encompassing senior leadership across various aspects of manufacturing sciences and engineering. Earlier career experience includes roles at Merck as Business Lead for Cancidas Manufacturing and as a Technical Operations Process Engineer. Terry Hudson earned a Ph.D. in Chemical Engineering from The University of Texas at Austin and a B.S. in Engineering Science from Trinity University.